Skip to main content
Erschienen in: European Archives of Oto-Rhino-Laryngology 1/2019

26.10.2018 | Review Article

The p.P240L variant of CDH23 and the risk of nonsyndromic hearing loss: a meta-analysis

verfasst von: Tianni Xu, Wei Zhu, Ping Wang

Erschienen in: European Archives of Oto-Rhino-Laryngology | Ausgabe 1/2019

Einloggen, um Zugang zu erhalten

Abstract

Purpose

We conducted a meta-analysis assessing the association between the p.P240L (c.C719T) variant and the risk of nonsyndromic hearing loss (NSHL).

Methods

Literatures that reported prevalence rates were identified using PubMed, EMBASE, OVID, Cochrane library, Web of Science, Chinese National Knowledge Infrastructure, Wanfang Databases for the period from inception to August 2017. Random and fixed effects models were used to generate pooled ORs and I2 values. The heterogeneity assumption decided the effect model.

Results

A total of four relevant studies were included in the meta-analysis. The results of meta-analysis indicated that the p.P240L variant was correlated with the risk of NHSL in Asian populations (OR = 10.17, 95% CI = 2.74–37.82, P = 0.001). The T allele of p.P240L was associated with a 12-fold higher risk of NSHL than the C allele (OR = 11.68; 95% CI = 3.16–43.24, P < 0.001). Specifically, p.P240L heterozygotes (OR = 8.49; 95% CI = 2.28–31.59, P = 0.001), had a significantly higher risk of NSHL. Publication bias of our meta-analysis was attributed to the limited availability of relevant results and the number of studies included in our meta-analysis was relatively small.

Conclusions

The p.P240L variant increased the risk of NHSL in Asian populations, suggesting a remarkable ethnic specificity linked with susceptibility to this mutation.
Literatur
2.
Zurück zum Zitat Friedman TB, Griffith AJ (2003) Human nonsyndromic sensorineural deafness. Annu Rev Genom Hum Genet 4:341–402CrossRef Friedman TB, Griffith AJ (2003) Human nonsyndromic sensorineural deafness. Annu Rev Genom Hum Genet 4:341–402CrossRef
3.
Zurück zum Zitat Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ et al (2002) CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 71:262–275CrossRefPubMedPubMedCentral Astuto LM, Bork JM, Weston MD, Askew JW, Fields RR, Orten DJ et al (2002) CDH23 mutation and phenotype heterogeneity: a profile of 107 diverse families with Usher syndrome and nonsyndromic deafness. Am J Hum Genet 71:262–275CrossRefPubMedPubMedCentral
4.
Zurück zum Zitat Mizutari K, Mutai H, Namba K, Miyanaga Y, Nakano A, Arimoto Y et al (2005) High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss. Orphanet J Rare Dis 10:60CrossRef Mizutari K, Mutai H, Namba K, Miyanaga Y, Nakano A, Arimoto Y et al (2005) High prevalence of CDH23 mutations in patients with congenital high-frequency sporadic or recessively inherited hearing loss. Orphanet J Rare Dis 10:60CrossRef
5.
Zurück zum Zitat Kim BJ, Kim AR, Lee C, Kim SY, Kim NK, Chang MY et al (2016) Discovery of CDH23 as a significant contributor to progressive postlingual sensorineural hearing loss in Koreans. PLoS One 11:e0165680CrossRefPubMedPubMedCentral Kim BJ, Kim AR, Lee C, Kim SY, Kim NK, Chang MY et al (2016) Discovery of CDH23 as a significant contributor to progressive postlingual sensorineural hearing loss in Koreans. PLoS One 11:e0165680CrossRefPubMedPubMedCentral
6.
Zurück zum Zitat Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed Stang A (2010) Critical evaluation of the Newcastle–Ottawa scale for the assessment of the quality of nonrandomized studies in meta-analyses. Eur J Epidemiol 25:603–605CrossRefPubMed
7.
Zurück zum Zitat DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMed DerSimonian R, Laird N (1986) Meta-analysis in clinical trials. Control Clin Trials 7:177–188CrossRefPubMed
8.
Zurück zum Zitat Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748 Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719–748
9.
Zurück zum Zitat Wagatsuma M, Kitoh R, Suzuki H, Fukuoka H, Takumi Y, Usami S (2007) Distribution and frequencies of CDH23 mutations in Japanese patients with non-syndromic hearing loss. Clin Genet 72:339–344CrossRefPubMed Wagatsuma M, Kitoh R, Suzuki H, Fukuoka H, Takumi Y, Usami S (2007) Distribution and frequencies of CDH23 mutations in Japanese patients with non-syndromic hearing loss. Clin Genet 72:339–344CrossRefPubMed
10.
Zurück zum Zitat Miyagawa M, Nishio SY, Usami S (2012) Prevalence and clinical features of hearing loss patients with CDH23 mutations: a large cohort study. PLoS One 7:e40366CrossRefPubMedPubMedCentral Miyagawa M, Nishio SY, Usami S (2012) Prevalence and clinical features of hearing loss patients with CDH23 mutations: a large cohort study. PLoS One 7:e40366CrossRefPubMedPubMedCentral
11.
Zurück zum Zitat Mutai H, Suzuki N, Shimizu A, Torii C, Namba K, Morimoto N et al (2013) Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis 8:172CrossRefPubMedPubMedCentral Mutai H, Suzuki N, Shimizu A, Torii C, Namba K, Morimoto N et al (2013) Diverse spectrum of rare deafness genes underlies early-childhood hearing loss in Japanese patients: a cross-sectional, multi-center next-generation sequencing study. Orphanet J Rare Dis 8:172CrossRefPubMedPubMedCentral
12.
Zurück zum Zitat Kim SY, Kim AR, Kim NK, Kim MY, Jeon EH, Kim BJ et al (2015) Strong founder effect of p.P240L in CDH23 in Koreans and its significant contribution to severe-to-profound nonsyndromic hearing loss in a Korean pediatric population. J Transl Med 13:263CrossRefPubMedPubMedCentral Kim SY, Kim AR, Kim NK, Kim MY, Jeon EH, Kim BJ et al (2015) Strong founder effect of p.P240L in CDH23 in Koreans and its significant contribution to severe-to-profound nonsyndromic hearing loss in a Korean pediatric population. J Transl Med 13:263CrossRefPubMedPubMedCentral
13.
Zurück zum Zitat Nele H, Smith JH, Van Camp G (2009) Function and expression pattern of nonsyndromic deafness genes. Curr Mol Med 9:546–564CrossRef Nele H, Smith JH, Van Camp G (2009) Function and expression pattern of nonsyndromic deafness genes. Curr Mol Med 9:546–564CrossRef
14.
15.
Zurück zum Zitat Nollet F, Kools P, van Roy F (2000) Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 299:551–572CrossRefPubMed Nollet F, Kools P, van Roy F (2000) Phylogenetic analysis of the cadherin superfamily allows identification of six major subfamilies besides several solitary members. J Mol Biol 299:551–572CrossRefPubMed
16.
Zurück zum Zitat Bolz H, von Brederlow B, Ramirez A, Bryda EC, Kutsche K, Nothwang HG et al (2001) Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 27:108–112CrossRefPubMed Bolz H, von Brederlow B, Ramirez A, Bryda EC, Kutsche K, Nothwang HG et al (2001) Mutation of CDH23, encoding a new member of the cadherin gene family, causes Usher syndrome type 1D. Nat Genet 27:108–112CrossRefPubMed
17.
Zurück zum Zitat Bork JM, Peters LM, Riazuddin S, Bernstein SL, Ahmed ZM, Ness SL et al (2001) Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 68:26–37CrossRefPubMed Bork JM, Peters LM, Riazuddin S, Bernstein SL, Ahmed ZM, Ness SL et al (2001) Usher syndrome 1D and nonsyndromic autosomal recessive deafness DFNB12 are caused by allelic mutations of the novel cadherin-like gene CDH23. Am J Hum Genet 68:26–37CrossRefPubMed
18.
Zurück zum Zitat Wu H, Feng Y, Jiang L, Pan Q, Liu Y, Liu C et al (2016) Application of a new genetic deafness microarray for detecting mutations in the deaf in China. PLoS One 11:e0151909CrossRefPubMedPubMedCentral Wu H, Feng Y, Jiang L, Pan Q, Liu Y, Liu C et al (2016) Application of a new genetic deafness microarray for detecting mutations in the deaf in China. PLoS One 11:e0151909CrossRefPubMedPubMedCentral
19.
Zurück zum Zitat Nishio SY, Usami S (2015) Deafness gene variations in a 1120 nonsyndromic hearing loss cohort: molecular epidemiology and deafness mutation spectrum of patients in Japan. Ann Otol Rhinol Laryngol 124(Suppl 1):49S–60SCrossRefPubMed Nishio SY, Usami S (2015) Deafness gene variations in a 1120 nonsyndromic hearing loss cohort: molecular epidemiology and deafness mutation spectrum of patients in Japan. Ann Otol Rhinol Laryngol 124(Suppl 1):49S–60SCrossRefPubMed
20.
Zurück zum Zitat Duman D, Sirmaci A, Cengiz FB, Ozdag H, Tekin M (2011) Screening of 38 genes identifies mutations in 62% of families with nonsyndromic deafness in Turkey. Genet Test Mol Biomark 15(1–2):29–33CrossRef Duman D, Sirmaci A, Cengiz FB, Ozdag H, Tekin M (2011) Screening of 38 genes identifies mutations in 62% of families with nonsyndromic deafness in Turkey. Genet Test Mol Biomark 15(1–2):29–33CrossRef
21.
Zurück zum Zitat Shahin H, Walsh T, Rayyan AA, Lee MK, Higgins J, Dickel D et al (2010) Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet 18:407–413CrossRefPubMed Shahin H, Walsh T, Rayyan AA, Lee MK, Higgins J, Dickel D et al (2010) Five novel loci for inherited hearing loss mapped by SNP-based homozygosity profiles in Palestinian families. Eur J Hum Genet 18:407–413CrossRefPubMed
22.
Zurück zum Zitat Yang T, Wei X, Chai Y, Li L, Wu H (2013) Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis 8:85CrossRefPubMedPubMedCentral Yang T, Wei X, Chai Y, Li L, Wu H (2013) Genetic etiology study of the non-syndromic deafness in Chinese Hans by targeted next-generation sequencing. Orphanet J Rare Dis 8:85CrossRefPubMedPubMedCentral
23.
Zurück zum Zitat Ganapathy A, Pandey N, Srisailapathy CR, Jalvi R, Malhotra V, Venkatappa M et al (2014) Non-syndromic hearing impairment in India: high allelic heterogeneity among mutations in TMPRSS3, TMC1, USHIC, CDH23 and TMIE. PLoS One 9:e84773CrossRefPubMedPubMedCentral Ganapathy A, Pandey N, Srisailapathy CR, Jalvi R, Malhotra V, Venkatappa M et al (2014) Non-syndromic hearing impairment in India: high allelic heterogeneity among mutations in TMPRSS3, TMC1, USHIC, CDH23 and TMIE. PLoS One 9:e84773CrossRefPubMedPubMedCentral
24.
Zurück zum Zitat Mori K, Moteki H, Miyagawa M, Nishio SY, Usami S (2016) Social health insurance-based simultaneous screening for 154 mutations in 19 deafness genes efficiently identified causative mutations in Japanese hearing loss patients. PLoS One 11:e0162230CrossRefPubMedPubMedCentral Mori K, Moteki H, Miyagawa M, Nishio SY, Usami S (2016) Social health insurance-based simultaneous screening for 154 mutations in 19 deafness genes efficiently identified causative mutations in Japanese hearing loss patients. PLoS One 11:e0162230CrossRefPubMedPubMedCentral
25.
Zurück zum Zitat Miyagawa M, Naito T, Nishio SY, Kamatani N, Usami S (2013) Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One 8:e71381CrossRefPubMedPubMedCentral Miyagawa M, Naito T, Nishio SY, Kamatani N, Usami S (2013) Targeted exon sequencing successfully discovers rare causative genes and clarifies the molecular epidemiology of Japanese deafness patients. PLoS One 8:e71381CrossRefPubMedPubMedCentral
26.
Zurück zum Zitat Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A et al (2011) Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 12(9):R89CrossRefPubMedPubMedCentral Brownstein Z, Friedman LM, Shahin H, Oron-Karni V, Kol N, Abu Rayyan A et al (2011) Targeted genomic capture and massively parallel sequencing to identify genes for hereditary hearing loss in Middle Eastern families. Genome Biol 12(9):R89CrossRefPubMedPubMedCentral
27.
Zurück zum Zitat Lebeko K, Sloan-Heggen CM, Noubiap JJ, Dandara C, Kolbe DL, Ephraim SS et al (2016) Targeted genomic enrichment and massively parallel sequencing identifies novel nonsyndromic hearing impairment pathogenic variants in Cameroonian families. Clin Genet 90:288–290CrossRefPubMedPubMedCentral Lebeko K, Sloan-Heggen CM, Noubiap JJ, Dandara C, Kolbe DL, Ephraim SS et al (2016) Targeted genomic enrichment and massively parallel sequencing identifies novel nonsyndromic hearing impairment pathogenic variants in Cameroonian families. Clin Genet 90:288–290CrossRefPubMedPubMedCentral
28.
29.
Zurück zum Zitat Park JH, Kim NK, Kim AR, Rhee J, Oh SH, Koo JW et al (2014) Exploration of molecular genetic etiology for Korean cochlear implantees with severe to profound hearing loss and its implication. Orphanet J Rare Dis 9:167CrossRefPubMedPubMedCentral Park JH, Kim NK, Kim AR, Rhee J, Oh SH, Koo JW et al (2014) Exploration of molecular genetic etiology for Korean cochlear implantees with severe to profound hearing loss and its implication. Orphanet J Rare Dis 9:167CrossRefPubMedPubMedCentral
Metadaten
Titel
The p.P240L variant of CDH23 and the risk of nonsyndromic hearing loss: a meta-analysis
verfasst von
Tianni Xu
Wei Zhu
Ping Wang
Publikationsdatum
26.10.2018
Verlag
Springer Berlin Heidelberg
Erschienen in
European Archives of Oto-Rhino-Laryngology / Ausgabe 1/2019
Print ISSN: 0937-4477
Elektronische ISSN: 1434-4726
DOI
https://doi.org/10.1007/s00405-018-5160-8

Weitere Artikel der Ausgabe 1/2019

European Archives of Oto-Rhino-Laryngology 1/2019 Zur Ausgabe

Update HNO

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.